Bazzi, Z. A., Lanoue, D., El-Youssef, M., Romagnuolo, R., Tubman, J., Cavallo-Medved, D., . . . Boffa, M. B. (2016). Activated thrombin-activatable fibrinolysis inhibitor (TAFIa) attenuates breast cancer cell metastatic behaviors through inhibition of plasminogen activation and extracellular proteolysis. BMC Cancer.

Bazzi, Zainab A., Danielle Lanoue, Mouhanned El-Youssef, Rocco Romagnuolo, Janice Tubman, Dora Cavallo-Medved, Lisa A. Porter, and Michael B. Boffa. "Activated Thrombin-activatable Fibrinolysis Inhibitor (TAFIa) Attenuates Breast Cancer Cell Metastatic Behaviors Through Inhibition of Plasminogen Activation and Extracellular Proteolysis." BMC Cancer 2016.

Bazzi, Zainab A., et al. "Activated Thrombin-activatable Fibrinolysis Inhibitor (TAFIa) Attenuates Breast Cancer Cell Metastatic Behaviors Through Inhibition of Plasminogen Activation and Extracellular Proteolysis." BMC Cancer 2016.